Literature DB >> 32363449

Indwelling catheterization, renal stones, and hydronephrosis are risk factors for symptomatic Staphylococcus aureus-related urinary tract infection.

Hiroyuki Kitano1,2, Norifumi Shigemoto3, Yumiko Koba4, Toshinori Hara4, Kashiyama Seiya4, Keitaro Omori3, Katsumi Shigemura5, Jun Teishima6, Masato Fujisawa5, Akio Matsubara6, Hiroki Ohge3.   

Abstract

PURPOSE: Staphylococcus aureus is a relatively uncommon causative agent of urinary tract infection (UTI). However, the clinical features of S. aureus-related UTI are unclear. Thus, we aimed to clarify how patients with S. aureus bacteriuria develop UTI and determine the features and clinical risk factors of symptomatic S. aureus-related UTI.
METHODS: We performed a retrospective study of patients at the Hiroshima University Hospital for whom S. aureus had been isolated from urine culture from January 2010 to December 2017. The characteristics (age, sex, body mass index, indwelling catheterization, renal stones, hydronephrosis, anticancer drug use, diabetes mellitus, steroid use, serum albumin, antibiotic use in the past 1 month, estimated glomerular filtration rate, benign prostate hyperplasia, and neurogenic bladder) of patients with UTI and those without UTI were compared, and the risk factors for S. aureus-related UTI were identified by multiple logistic regression model.
RESULTS: A total of 286 patients with S. aureus bacteriuria were analyzed; 33 patients developed UTI. The causative pathogens were methicillin-sensitive S. aureus and methicillin-resistant S. aureus (MRSA) in 14 and 19 patients, respectively, who developed UTI. This study demonstrated that indwelling catheterization, hydronephrosis, and renal stones are significantly associated with S. aureus-related UTI (p = 0.01, odds ratio = 3.1; and p < 0.01, odds ratio = 7.0; and p = 0.02, odds ratio = 1.2; respectively) and hypoalbuminemia in MRSA-related UTI (p < 0.01).
CONCLUSION: Paying attention to risk factors, specifically indwelling catheterization, renal stones, and hydronephrosis, will be an effective strategy for prevention of S. aureus-related UTI with persistent staphylococcal bacteriuria.

Entities:  

Keywords:  Hydronephrosis; Indwelling catheter; Renal stones; Staphylococcus aureus; Urinary tract infection

Mesh:

Year:  2020        PMID: 32363449     DOI: 10.1007/s00345-020-03223-x

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  18 in total

1.  Interaction of bladder glycoprotein GP51 with uropathogenic bacteria.

Authors:  D E Shupp Byrne; J F Sedor; M Soroush; P A McCue; S G Mulholland
Journal:  J Urol       Date:  2001-04       Impact factor: 7.450

2.  Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre Study Group.

Authors:  F W Goldstein
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-02       Impact factor: 3.267

3.  Isolation of Staphylococcus aureus from the urinary tract: association of isolation with symptomatic urinary tract infection and subsequent staphylococcal bacteremia.

Authors:  Robert R Muder; Carole Brennen; John D Rihs; Marilyn M Wagener; Asia Obman; Janet E Stout; Victor L Yu
Journal:  Clin Infect Dis       Date:  2005-11-23       Impact factor: 9.079

4.  Quantifying the relationship between Staphylococcus aureus bacteremia and S. aureus bacteriuria: a retrospective analysis in a tertiary care hospital.

Authors:  Miquel B Ekkelenkamp; Jan Verhoef; Marc J Bonten
Journal:  Clin Infect Dis       Date:  2007-04-18       Impact factor: 9.079

5.  Epidemiological and clinical characteristics of methicillin sensitive Staphylococcus aureus (MSSA) bacteriuria.

Authors:  Lisa Saidel-Odes; Klaris Riesenberg; Francisc Schlaeffer; Abraham Borer
Journal:  J Infect       Date:  2009-01-13       Impact factor: 6.072

6.  Concordance of renal stone culture: PMUC, RPUC, RSC and post-PCNL sepsis-a non-randomized prospective observation cohort study.

Authors:  Annerleim Walton-Diaz; José Ignacio Vinay; Jaime Barahona; Pieter Daels; Mariano González; Juan Pablo Hidalgo; Cristian Palma; Pablo Díaz; Alfredo Domenech; Rodrigo Valenzuela; Fernando Marchant
Journal:  Int Urol Nephrol       Date:  2016-11-15       Impact factor: 2.370

7.  Primary Staphylococcus aureus urinary tract infection: the role of undetected hematogenous seeding of the urinary tract.

Authors:  I G Baraboutis; E P Tsagalou; J L Lepinski; I Papakonstantinou; V Papastamopoulos; A T Skoutelis; S Johnson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-30       Impact factor: 3.267

8.  Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain.

Authors:  S P Barrett; M A Savage; M P Rebec; A Guyot; N Andrews; S B Shrimpton
Journal:  J Antimicrob Chemother       Date:  1999-09       Impact factor: 5.790

9.  A nitrate reductase-based colorimetric assay for the study of bacterial adherence.

Authors:  H A Shoeb; A F Tawfik; A M Shibl
Journal:  J Appl Bacteriol       Date:  1991-09

10.  The clinical significance of Staphylococcus aureus bacteriuria.

Authors:  M Arpi; J Renneberg
Journal:  J Urol       Date:  1984-10       Impact factor: 7.450

View more
  3 in total

1.  Prediction Model for Urinary Tract Infection in Pediatric Urological Surgery Patients.

Authors:  Yi Chen; Xiao-Hua Ge; Qun Yu; Ying Wang; Sheng-Mei Zhu; Jia-Ni Yuan; Wen Zong
Journal:  Front Public Health       Date:  2022-06-22

2.  Investigation of Virulence Genes of the Predominant Bacteria Associated with Renal Stones and their Correlation with Postoperative Septic Complications.

Authors:  Asmaa E Ahmed; Hassan Abol-Enein; Amira Awadalla; Heba El Degla; Omar A El-Shehaby
Journal:  Infect Drug Resist       Date:  2022-07-09       Impact factor: 4.177

Review 3.  Association of Kidney Stones and Recurrent UTIs: the Chicken and Egg Situation. A Systematic Review of Literature.

Authors:  Francesco Ripa; Amelia Pietropaolo; Emanuele Montanari; B M Zeeshan Hameed; Vineet Gauhar; Bhaskar K Somani
Journal:  Curr Urol Rep       Date:  2022-07-25       Impact factor: 2.862

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.